Page 131 - Prostate News Today

Amendment issue. >> some are saying he could get off the air. speaking of comebacks harrison ford was spotted shooting the fifth indiana jones movie in england this week, he is 78 years old and that age you might call this indiana jones and the raiders of the lost prostate. there is a cancellation controversy around the character owing to this scene. >> i learned today you in the last 10 years. >> i never meant to hurt you. >> i was a child, i was in love. it was wrong and you knew it. >> you kn...

Should get off the air. speaking of come back, harrison ford was spotted shooting the fifth indiana jones movie in england. he is 78 years old. at that age, you may call this "indiana jones and the raiders of the lost prostate." theres controversy surrounding this scene. >> -- last ten years. >> i never meant to hurt you. >> i was a child. i was in love. it was wrong, and you knew it. >> you knew what you were doing. >> now i do. >> raymond: that shows indianhead an inappropriate relationship wi...

Oncotarget published "The presence of polymorphisms in genes controlling neurotransmitter metabolism and disease prognosis in patients with prostate...

Prostate cancer is the second most common cancer among men, according to the American Cancer Society. It's also one of the trickiest cancers to diagnose and treat.

In a recently published article in the journal Frontiers in Immunology, scientists have reviewed the existing literature on antiviral and anti-inflammatory efficacy of resveratrol-based inhaled formulations in preventing SARS-CoV-2 infection and reducing COVID-19 severity.

In a large, international retrospective study, men at high risk for death from prostate cancer had a significant reduction in all-cause mortality if...

Cancer researchers say they have established a new, life-extending treatment option for men with prostate cancer that has spread and become resistant to hormone therapy.

The impact of deploying Artificial Intelligence (AI) for radiation cancer therapy in a real-world clinical setting has been tested by Princess Margaret researchers in a unique study involving physicians and their patients.

Novartis Pharma AG: Novartis 177Lu-PSMA-617 significantly improves overall survival and radiographic progression-free survival for men with metastatic castration-resistant prostate cancer in Phase III VISION study 177 Lu-PSMA-617 plus best standard of care had a 38% reduction in risk of death (median OS benefit of 4 months) and a 60% reduction in the risk of radiographic disease progression or death (median rPFS benefit of 5 months) compared to best standard of care alone 1 Significant improvem...

Moffitt Cancer Center presents new data from dozens of clinical research studies at ASCO Moffitt Cancer Center, a national leader in cancer care and research and the only National Cancer Institute-designated Comprehensive Cancer Center based in Florida, is presenting new data from dozens of clinical research studies at this years American Society of Clinical Oncology (ASCO) Annual Meeting, the worlds largest clinical cancer research meeting. Moffitt investigators will lead 25 abstract presentat...